C44.1392
Sebaceous cell carcinoma of skin of left lower eyelid, including canthus
Clinical Classification Guidelines
Medical Intelligence & Overview
Sebaceous cell carcinoma is a rare but aggressive form of skin cancer that originates in the sebaceous glands, which are responsible for producing oil in the skin. When it occurs on the eyelid, particularly on the lower lid including the canthus (the corner where the eyelids meet), it can be challenging to diagnose because it mimics other more benign conditions. Recognizing the key features and the importance of prompt medical attention can be crucial for effective treatment.
Causes & Symptoms
Clinical Causes: Chronic sun exposure, especially in individuals with prolonged outdoor activity History of radiation exposure to the eye region Genetic predispositions, such as Muir-Torre syndrome Pre-existing skin conditions or inflammation that may mask early signs Older age, as the risk increases with advancing years
Key Symptoms: A painless, firm, or nodular lesion on the eyelid A lesion that may appear yellowish or skin-colored Possible ulceration or crusting of the affected area Progressive swelling or thickening of the eyelid Changes in the shape or appearance of the eyelid or canthus
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a combination of clinical examination and histopathological analysis. When a suspicious eyelid lesion is observed, a biopsy is essential to confirm the presence of sebaceous carcinoma. Imaging studies, such as ultrasound or MRI, may be utilized to assess the extent of the tumor and involvement of surrounding tissues. Early detection is vital to prevent local tissue destruction and metastasis.
Treatment Protocols: Treatment strategies generally include surgical removal of the tumor, such as excisional surgery or eyelid-sparing techniques. In some cases, mohs micrographic surgery can be employed to ensure complete removal while preserving as much healthy tissue as possible. Additional therapies might involve radiation therapy or topical chemotherapy, especially in cases where surgery is not feasible or for residual disease. Due to the aggressive nature of sebaceous carcinoma, a multidisciplinary approach involving ophthalmologists, oncologists, and dermatologists is often recommended.
Clinical Advice & FAQs
Billing Guidance
Is C44.1392 a billable ICD-10 code?
Yes, C44.1392 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C44.1392?
Clinical documentation must specify the nature of Sebaceous cell carcinoma of skin of left lower eyelid, including canthus and any associated comorbidities for accurate reporting.
Cite this Clinical Reference